- |||||||||| budesonide / Generic mfg.
Retrospective data, Journal: Budesonide versus systemic corticosteroids in IgA Nephropathy: A retrospective, propensity-matched comparison. (Pubmed Central) - Jul 8, 2020 The median reduction in hematuria at 24-month was 72% (IQR: -90%; -45%) in the budesonide group and 73% (IQR: -85%; 18%) in the corticosteroid group, respectively (P = .22, for between group difference). Treatment with budesonide was well tolerated with minimal side effects.Budesonide (Budenofalk) was effective in the treatment of patients with IgAN at high-risk of progression in terms of reducing proteinuria, hematuria and preserving renal function over 24 months of therapy.
- |||||||||| methylprednisolone oral / Generic mfg., budesonide / Generic mfg.
[VIRTUAL] Asthma Can Break Your Heart (ATS 2020 Virtual) - Jul 6, 2020 - Abstract #ATSI2020ATS-I_7388; Our case adds to the body of evidence linking the two together. The use of IV B2 agonist in our case might further add weight to B2 agonists being implicated in TCM with asthma.
- |||||||||| ceftriaxone / Generic mfg., meropenem / Generic mfg., Daewon Pharmaceutical
[VIRTUAL] Successful Management of Pediatric Plastic Bronchitis in an African Context (ATS 2020 Virtual) - Jul 6, 2020 - Abstract #ATSI2020ATS-I_7088; CASE REPORT A seven-year old known to have SCD - on daily hydroxyurea, folate and penicillin V - presented with a two-day history of cough, fever and difficulty in breathing...He was admitted to the intensive care unit, commenced on intravenous high-dose ceftriaxone, amikacin, and maintenance fluids...He completed 10 days of meropenem-vancomycin...He was discharged home to complete his azithromycin/fluconazole course, continue incentive spirometry, daily inhaled budesonide, and salbutamol when necessary...DISCUSSION A high index of clinical suspicion made bronchoscopy necessary leading to an optimal clinical outcome for our patient. We report this case to alert health workers in our context that plastic bronchitis in ACS occurs and can have a good outcome if managed correctly.
- |||||||||| budesonide / Generic mfg.
[VIRTUAL] Changes in the Airway Hyperresponsiveness to Dosed Physical Exercise in Asthma Patients with Osmotic Airway Hyperresponsiveness Under Dynamic Observation (ATS 2020 Virtual) - Jul 6, 2020 - Abstract #ATSI2020ATS-I_6022; In 54 patients (average 39.6±1.1 years old) with mild persistent asthma and osmotic airway hyperresponsiveness, the lung function and airway response to DPE (∆FEV 1 ) were assessed initially and after 24 weeks of controller treatment with combination ICS/LABA (budesonide/formoterol 160/4,5 mcg/dose on 2 inhalations per day)...In patients with a negative response to DPE, FEV 1 was 96.6±2.84% (p=0.48); ∆FEV 1 was -4.4±1.4% (p=0.049), 6 patients had exercise-induced bronchoconstriction. Conclusion : In asthma patients with osmotic airway hyperresponsiveness and exercise-induced bronchoconstriction, controller antiinflammatory therapy does not effectively normalize airway responsiveness to dosed physical exercise.
- |||||||||| budesonide / Generic mfg.
[VIRTUAL] Pulmonary Surgical Treatment in a Young Patient with Cystic Bronchiectasis (ATS 2020 Virtual) - Jul 6, 2020 - Abstract #ATSI2020ATS-I_4798; Prophylactic macrolide prescribed three times a week plus formoterol 6mcg associated with budesonide 200mcg twice daily...Postoperative complications include empyema, hemorrhage, prolonged air leakage, and insufficient pulmonary expansion due to persistent atelectasis or suppuration. Segmentectomy or lobectomy by video-assisted thoracoscopic surgery (VATS) is an option with a lower incidence of complications and shorter hospitalizations.
- |||||||||| budesonide / Generic mfg., budesonide/salbutamol (PT027) / AstraZeneca, Avillion, warfarin / Generic mfg.
[VIRTUAL] Progressive Congenital Lobar Emphysema in an Elderly Adult (ATS 2020 Virtual) - Jul 6, 2020 - Abstract #ATSI2020ATS-I_4030; It remains unknown which potential factors might cause worsening emphysematous changes to present later in adults with this disease. Additionally, we propose investigation of additional treatment options for elderly patients with this condition, including the role of endobronchial valve placement.
- |||||||||| [VIRTUAL] Refractory Bronchospasm for Two Weeks in a Current Smoker (ATS 2020 Virtual) - Jul 6, 2020 - Abstract #ATSI2020ATS-I_4028;
On day 8, albuterol was reduced to every 2 hours, ketamine was stopped and furosemide and aformoterol were begun...By day 12, the patient improved on as-needed albuterol, with scheduled aformoterol, budesonide, azithromycin and methylprednisolone (latter twice-daily)...In true RB, the greatest benefit has been seen with volatile anesthetic gases, with most literature in the pediatric population. It can be logistically challenging to arrange for anesthetic gas administration in the ICU.
- |||||||||| budesonide / Generic mfg., azithromycin / Generic mfg.
[VIRTUAL] Unusual Cause of Recurrent Wheezing in an Infant (ATS 2020 Virtual) - Jul 6, 2020 - Abstract #ATSI2020ATS-I_3350; He was managed as asthma with bronchodilators and nebulized budesonide with minimal improvement...He was started on pulse steroids, thrice weekly Azithromycin, and airway clearance with significant improvement in symptoms and frequency of exacerbations...PIBO has high morbidity and patients with recurrent exacerbation requiring frequent hospitalizations, so early diagnosis is crucial. In conclusion, pediatric patients who fail to respond to conventional treatment for recurrent wheezing warrant further evaluation for other etiologies.
- |||||||||| budesonide / Generic mfg., Pulmicort Turbuhaler (budesonide dry-powder inhaler) / AstraZeneca
[VIRTUAL] Predicting Pharmacokinetics from Three Marketed Dry Powder Inhalers (ATS 2020 Virtual) - Jul 6, 2020 - Abstract #ATSI2020ATS-I_2669; In the present work, we link real-world emulative in vitro measurements of inhaler performance with numerical models of lung deposition and pharmacokinetics for budesonide (BUD) delivered from three marketed dry powder inhalers (DPIs) to illustrate how such a process can inform device/formulation design...Conclusions Coupling emulative in vitro experimentation with the modeling of regional lung deposition, ASL, and drug disposition allows for predictions of systemic drug exposure. The present method may prove useful in drug development.
- |||||||||| budesonide / Generic mfg.
[VIRTUAL] Preventer Therapy for Mild Asthma: A Qualitative Study of Patients' Treatment Experiences (ATS 2020 Virtual) - Jul 6, 2020 - Abstract #ATSI2020ATS-I_2196; Findings showed that, overall, patients perceived similar symptom frequency and lower treatment burden with as-needed budesonide-formoterol but had more concern about reliever effectiveness. Shared decision-making and good doctor-patient communication are recommended to increase patient inclusion in treatment choices for mild asthma.
- |||||||||| budesonide / Generic mfg.
[VIRTUAL] MicroRNA Correlates of Asthma Symptoms Changes During Daily Inhaled Corticosteroid Treatment (ATS 2020 Virtual) - Jul 6, 2020 - Abstract #ATSI2020ATS-I_544; Here we investigate asthma-related symptoms, within the framework of the Global Initiative for Asthma (GINA) symptom control score, following 2 months of daily treatment with inhaled budesonide (a corticosteroid) or placebo in the Childhood Asthma Management Program (CAMP)...Funding. NIH supported: R01 HL129935, R01 HL127332, R01 NR013391, R01 HL139496.
- |||||||||| budesonide / Generic mfg.
Journal: Disseminated Strongyloides stercoralis infection in a dog following long-term treatment with budesonide. (Pubmed Central) - Jul 4, 2020 Findings illustrated the importance of performing diagnostic testing, including routine fecal examination, to rule out infectious causes of diarrhea before beginning empirical treatment with glucocorticoids such as budesonide. Further, repeated fecal examinations, including Baermann tests, should be considered if a positive response to glucocorticoids is not observed.
- |||||||||| budesonide / Generic mfg.
Journal: Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma. (Pubmed Central) - Jul 2, 2020 The limited available evidence suggests that budesonide/formoterol reliever therapy has greater potency and efficacy than budesonide/formoterol fixed dose maintenance plus SABA reliever therapy in reducing the risk of a severe exacerbation. This is an important concept which has the potential to guide clinical practice in asthma, although the small number of studies available highlights the need for further research to better define these pharmacological properties.
|